Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial

JACC Cardiovascular Interventions

27 Giugno Giu 2016 5 months ago
  • Bartorelli A

The study compared, by intravascular ultrasound (IVUS), acute gain at the site of the pre-procedural minimal lumen area (MLA) achieved by either the Absorb scaffold or the Xience stent and identified the factors contributing to the acute performance of these devices.

Reference
Sotomi Y, Ishibashi Y, Suwannasom P, Nakatani S, Cho YK, Grundeken MJ, Zeng Y, Tateishi H, Smits PC, Barragan P, Kornowski R, Gershlick AH, Windecker S, van Geuns RJ, Bartorelli AL, de Winter RJ, Tijssen J, Serruys PW, Onuma Y. Acute Gain in Minimal Lumen Area Following Implantation of Everolimus-Eluting ABSORB Biodegradable Vascular Scaffolds or Xience Metallic Stents: Intravascular Ultrasound Assessment From the ABSORB II Trial. JACC Cardiovasc Interv 2016;9(12):1216-27

Go to PubMed